Go to content

European Society for ME - Research & Knowledge

  • ESME
  • Contact
  • Search
  • Translation
  • Home
  • XMRV/MLV Seminar Oslo
  • Danish Conference
  • Recent UPDATES
  • ESME
  • News
    • Archive
  • ME - Facts and Figures
  • Treatment
  • Testing
  • Kids
  • Resources/Guidelines
  • Public Conferences
  • Media
  • Donate
  • Comments
  • XMRV
  • ME Organisations
  • FORUM

You are here:

  • Home
  • News
  • Norwegian research Rituximab in ME/Chronic Fatigue Syndrome, PloS ONE, Fluge and Mella

Norwegian research Rituximab in ME/Chronic Fatigue Syndrome, PloS ONE, Fluge and Mella

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study.

http://esme-eu.com/getfile.php/Files/journal.pone.0026358%5B1%5D.pdf

ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling